Access in all areas? a round up of developments in market access and health technology assessment: part 4-Reference-Cited by-同舟云学术

Access in all areas? a round up of developments in market access and health technology assessment: part 4

Published:2024-06 Issue:6 Volume:13 Page:
ISSN:2042-6305
Container-title:Journal of Comparative Effectiveness Research
language:en
Short-container-title:J. Comp. Eff. Res.

Author:

Beattie Alice¹,Treharne Catrin¹,Ramagopalan Sreeram V¹²

Affiliation:

1. Lane Clark & Peacock LLP, London, W1U 1DQ, UK

2. Centre for Pharmaceutical Medicine Research, King's College London, SE1 9NH, UK

Abstract

In this latest update, we look at recent developments in market access including the pricing agreement of Libmeldy ® by the Beneluxa Initiative, the financial impact of managed entry agreements in Italy and the restructuring of Agenzia Italiana del Farmaco (AIFA). We also highlight the collaboration between FINOSE and the New Expensive Drug (NED) section of the Nordic Pharmaceutical Forum.

Publisher

Becaris Publishing Limited

Link

https://becarispublishing.com/doi/pdf/10.57264/cer-2024-0060

Reference25 articles.

1. Health technology assessment for cancer medicines across the G7 countries and Oceania: an international, cross-sectional study;Jenei K;Lancet Oncol.,2023

2. Access in all areas? A round up of developments in market access and health technology assessment: part 1

3. European Commission. Regulation on Health Technology Assessment (2024). Available at: https://health.ec.europa.eu/health-technology-assessment/regulation-health-technology-assessment_en

4. Beneluxa Initiative. Available at: https://beneluxa.org/collaboration

5. Beneluxa Initiative. About Beneluxa – statements (2021). Available at: https://beneluxa.org/statements